Vripio 7.5 Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Pioglitazone (7.5mg)
Overview Vripio 7.5 Tablet
Glucovance 7.5mg tablets are indicated for adult patients with type 2 diabetes to manage blood glucose levels. This helps mitigate serious diabetic complications such as vision impairment and renal dysfunction. Glucovance 7.5mg may be administered alone or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes efficacy. Dosage adjustments, determined by your physician, may be necessary based on treatment response. Continuous use is crucial, even with controlled blood sugar or feeling well; abrupt cessation can elevate glucose levels, risking kidney damage, blindness, neuropathy, and limb loss. Remember, this medication is part of a comprehensive plan including diet, exercise, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Common side effects include headache, sinus inflammation, myalgia, and sore throat. Report persistent or bothersome side effects to your physician. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of prior heart disease, thyroid disorders, or hormonal imbalances before commencing treatment, as Glucovance 7.5mg may be unsuitable. Pregnant or lactating women should consult their physician prior to use. Regular blood glucose monitoring and blood tests to assess blood cell counts and liver function may be recommended.
Primary Ingredients of Vripio 7.5 Tablet
No text provided to rephrase.
Uses of Vripio 7.5 Tablet
Managing type 2 diabetes
Major Benefits of Vripio 7.5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vripio 7.5mg tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Vripio 7.5 Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Vripio 7.5 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vripio 7.5mg tablets can be consumed with or without food, however, consistent timing is recommended.
How Vripio 7.5 Tablet works:
Glucovance 7.5mg tablets help manage diabetes by enhancing the body's response to insulin, a hormone regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vripio 7.5 Tablet and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Vripio 7.5 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Exercise caution when administering Vripio 7.5 Tablet to breastfeeding mothers. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system. Closely observe the infant's blood glucose levels while the mother is taking Vripio 7.5 Tablet.
DrivingSAFE
Driving ability is typically unaffected by Vripio 7.5 Tablet.
KidneySAFE IF PRESCRIBED
Vripio 7.5mg tablets can be administered to patients with kidney impairment without requiring a modification of the prescribed dosage.
LiverCAUTION
Patients with liver impairment should use Vripio 7.5 mg tablets cautiously, potentially requiring dosage modification under medical supervision. Vripio 7.5 mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Vripio 7.5 Tablet :
Omit any missed Vripio 7.5 Tablet dose and resume your usual medication regimen; avoid taking a double dose.
Facts to Know About Vripio 7.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | PPARγ agonist (thiazolidinedione) |
3,018 People bought this recently